Rapid and sustained antidepressant effects of vaporized N,N-Dimethyltryptamine: A Phase 2a clinical trial in Treatment-Resistant Depression. episode artwork

EPISODE · Apr 18, 2025 · 9 MIN

Rapid and sustained antidepressant effects of vaporized N,N-Dimethyltryptamine: A Phase 2a clinical trial in Treatment-Resistant Depression.

from NPP BrainPod

Draulio Araujo, professor at the Brain Institute in the University of Rio Grande Norte in Natal, Brazil, has been studying ayahuasca for more than 20 years. It’s a psychedelic plant used in rituals in South America that has also been researched for its potential to treat depression. The effects of ayahuasca can last for hours and also lead to side effects including vomiting and diarrhea. The active psychedelic drug in ayahuasca is DMT, and so Dr. Araujo and his colleagues decided to conduct the first test of DMT itself, which is also an endogenous chemical and has been demonstrated to be safe.Read the full article here: https://www.nature.com/articles/s41386-025-02091-6 Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Apr 18, 2025

Embed this episode

NOW PLAYING

Rapid and sustained antidepressant effects of vaporized N,N-Dimethyltryptamine: A Phase 2a clinical trial in Treatment-Resistant Depression.

0:00 9:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of NPP BrainPod?

This episode is 9 minutes long.

When was this NPP BrainPod episode published?

This episode was published on April 18, 2025.

Can I download this NPP BrainPod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!